Funding for this research was provided by:
Agency for Healthcare Research and Quality (R01-HS020642)
Patient-Centered Outcomes Research Institute (R24HS022134)
Received: 6 January 2018
Revised: 29 May 2018
Accepted: 5 June 2018
First Online: 22 June 2018
Compliance with ethical standards
: Dr. Gulshan Sharma served on the advisory board of Sunovion and Mylan Pharmaceuticals. The remaining authors have no potential conflicts of interest related to the content of manuscript.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board of University of Texas Medical Branch and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was not needed due to the nature of the study.